Compounds for use in a diagnostic agent for detecting, imaging, and/or monitoring a pathological disorder associated with matrix metalloproteinase activity at a site of interest in a patient are disclosed. Compositions and kits containing the compounds are also disclosed. In addition, methods of detecting, imaging, and/or monitoring the presence of matrix metalloproteinase or a pathological disorder associated with matrix metalloproteinase activity in a patient are disclosed.
揭示了用于诊断剂的化合物,用于检测、成像和/或监测患者感兴趣部位处与基质
金属
蛋白酶活性相关的病理紊乱。还揭示了含有这些化合物的组合物和试剂盒。此外,还揭示了检测、成像和/或监测患者体内基质
金属
蛋白酶或与基质
金属
蛋白酶活性相关的病理紊乱存在的方法。